Arkolith/Insider Trading/IRWD/Form 4

MCCOURT Thomas A

Chief Executive Officer, DirectorIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed Feb 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$740K
Net Open-Market Flow
-$740K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Sell(S)104K$3.66$379K1.5M
Feb 23, 2026Sell(S)95K$3.81$361K1.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-071496) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for IRONWOOD PHARMACEUTICALS INC

Build

Ask your agent about IRWD insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-071496"
Ask your agent
Use Arkolith to summarize insider buying and selling at IRONWOOD PHARMACEUTICALS INC
over the last 90 days and cite the filings.